Kwangdong Healthbio Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Public

  • Employees
  • 194

Employees

  • Stock Symbol
  • 086220

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.90
  • (As of Friday Closing)

Kwangdong Healthbio General Information

Description

Kwangdong Healthbio Co Ltd formerly BL Healthcare Corp is a Bio-venture company, which develops, manufactures, and sells health functional food and pharmaceutical products. The Company's products include weight-loss pills, vitamins, and other nutrition supplements. It also produces personal care items such as cosmetics, hair care products, and skincare products.

Contact Information

Formerly Known As
Natural F&P Corp, Natural F and P, Natural FP, Naturals, BL Healthcare (Pharmaceuticals)
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 39, Yangcheongsongdae-gil Ochang-eup
  • Cheongwon-gu
  • Cheongju, Chungcheongbuk 28118
  • South Korea
+82
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 39, Yangcheongsongdae-gil Ochang-eup
  • Cheongwon-gu
  • Cheongju, Chungcheongbuk 28118
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kwangdong Healthbio Stock Performance

As of 13-Nov-2026, Kwangdong Healthbio’s stock price is $0.90. Its current market cap is $9.5M.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.90 $0.81 $0.41 - $1.17 $9.5M 210.26 -$0.04

Kwangdong Healthbio Financials Summary

As of 31-Dec-2025, Kwangdong Healthbio has a trailing 12-month revenue of $47.1M.

In Thousands,
USD
TTM 31-Dec-2025 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 27,647 27,647 27,874 42,903
Revenue 47,065 47,065 48,006 61,308
EBITDA 2,569 2,569 1,286 3,684
Net Income (450) (450) (1,437) 436
Total Assets 43,199 43,199 35,940 44,152
Total Debt 19,735 19,735 17,241 21,212
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kwangdong Healthbio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kwangdong Healthbio‘s full profile, request access.

Request a free trial

Kwangdong Healthbio Patents

Kwangdong Healthbio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2017018791-A1 Ginseng fruit extract containing alcoholic liver damage preventive functional ingredient, and preparation method therefor Inactive 27-Jul-2015
WO-2007091801-A1 A sheet device comprising bio-cellulose for alleviating skin damage and relieving skin problem Inactive 07-Feb-2006
WO-2005067940-A1 Novel use of water soluble glucan oligomer isolated from saccharomyces cerevisiae is2 for prevention and treatment of avian flu Inactive 19-Jan-2004
WO-2005044291-A1 Grape seed extract having neuronal cell-protecting activity and the composition comprising the same for prepenting and treating degenerative brain disease Inactive 07-Nov-2003
US-20070122504-A1 Grape seed extract having neuronal cell-protection activity and the composition comprising the same for preventing and treating degenerative brain disease Inactive 07-Nov-2003 A61K36/87
To view Kwangdong Healthbio’s complete patent history, request access »

Kwangdong Healthbio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kwangdong Healthbio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kwangdong Healthbio‘s full profile, request access.

Request a free trial

Kwangdong Healthbio Investments (1)

Kwangdong Healthbio’s most recent deal was a Corporate Asset Purchase with UID (21898.2 Square Meters Facility Site in Cheongju, South Korea) for . The deal was made on 04-Nov-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
UID (21898.2 Square Meters Facility Site in Cheongju, South Korea) 04-Nov-2019 Corporate Asset Purchase Buildings and Property
To view Kwangdong Healthbio’s complete investments history, request access »

Kwangdong Healthbio ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Food Products

Industry

Rank

Percentile

Packaged Foods

Subindustry

Rank

Percentile

To view Kwangdong Healthbio’s complete esg history, request access »

Kwangdong Healthbio FAQs

  • When was Kwangdong Healthbio founded?

    Kwangdong Healthbio was founded in 1992.

  • Where is Kwangdong Healthbio headquartered?

    Kwangdong Healthbio is headquartered in Cheongju, South Korea.

  • What is the size of Kwangdong Healthbio?

    Kwangdong Healthbio has 194 total employees.

  • What industry is Kwangdong Healthbio in?

    Kwangdong Healthbio’s primary industry is Pharmaceuticals.

  • Is Kwangdong Healthbio a private or public company?

    Kwangdong Healthbio is a Public company.

  • What is Kwangdong Healthbio’s stock symbol?

    The ticker symbol for Kwangdong Healthbio is 086220.

  • What is the current stock price of Kwangdong Healthbio?

    As of 13-Nov-2026 the stock price of Kwangdong Healthbio is $0.90.

  • What is the current market cap of Kwangdong Healthbio?

    The current market capitalization of Kwangdong Healthbio is $9.5M.

  • What is Kwangdong Healthbio’s current revenue?

    The trailing twelve month revenue for Kwangdong Healthbio is $47.1M.

  • What is Kwangdong Healthbio’s annual earnings per share (EPS)?

    Kwangdong Healthbio’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process